Innovis Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.26M Buy
8,081
+7
+0.1% +$1.16K 0.48% 39
2023
Q2
$1.34M Sell
8,074
-73
-0.9% -$11.8K 0.49% 40
2023
Q1
$1.26M Buy
8,147
+224
+3% +$36.2K 0.51% 42
2022
Q4
$1.4M Buy
+7,923
New +$1.37M 0.63% 37

Other funds holding JNJ

Innovis Asset Management's JNJ Position: Q3 2023 in Review

Innovis Asset Management increased its Johnson & Johnson (JNJ) stake by 0.09% in Q3 2023, buying an estimated $1.16K and bringing the position to 8,081 shares worth $1.26M. The position accounts for 0.48% of the portfolio, ranked #39.

Innovis Asset Management first reported a position in JNJ in Q4 2022 and has held it in 4 quarters since. The position peaked at $1.4M in Q4 2022. 3,682 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Innovis Asset Management held 8,081 shares of Johnson & Johnson worth $1.26M as of Q3 2023.
  • Innovis Asset Management bought 7 Johnson & Johnson shares in Q3 2023, an estimated $1.16K.
  • Johnson & Johnson made up 0.48% of Innovis Asset Management's portfolio in Q3 2023, its #39 holding.
  • Innovis Asset Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 4 quarters since.
  • Innovis Asset Management's Johnson & Johnson position peaked at $1.4M in Q4 2022.
  • 3,682 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.